← All indications
Urogenital Neoplasms
Tumors or cancer of the UROGENITAL SYSTEM in either the male or the female.
Subtype terms (4)
More specific conditions that are subtypes of Urogenital Neoplasms in the MeSH hierarchy.
- Genital Neoplasms, Female
118 drugs (66 approved, 52 experimental)
- Genital Neoplasms, Male
18 drugs (13 approved, 5 experimental)
- Urologic Neoplasms
56 drugs (35 approved, 21 experimental)
- Venereal Tumors, Veterinary
Drugs by status
Phase 4 trials (2)
Phase 2 trials (41)
- lutetium (177Lu) vipivotide tetraxetan
- axitinib
- anlotinib
- atezolizumab
- olaparib
- gemcitabine
- paclitaxel
- imatinib
- nivolumab
- ixabepilone
- pembrolizumab
- lenvatinib
- motexafin gadolinium
- niraparib
- palbociclib
- pemetrexed
- ipilimumab
- sunitinib
- carboplatin
- riluzole
- avutometinib
- bevacizumab
- defactinib
- ctt1057
- enfortumab vedotin
- docetaxel
- varlilumab
- cisplatin
- relatlimab
- toripalimab
- +11 more
Phase 1 trials (18)
Other trials (5)
Organizations
Organization Involved with Phase 4 Indications (1)
Organization Involved with Phase 3 Indications (1)
Organization Involved with Phase 2 Indications (27)
- Bristol-Myers Squibb
- Roche
- Pharmacyclics
- Eli Lilly
- Genentech
- Pfizer
- Progenics
- Novartis
- Catalysis SL
- Celldex Therapeutics
- NanOlogy, LLC
- PharmaMar
- TesoRx Pharma, LLC
- British Columbia Cancer Agency
- National Cancer Institute (NCI)
- Cedars-Sinai Medical Center
- University of London
- Harvard University
- Gynecologic Oncology Group
- Nanjing Medical University
- Tel Aviv University
- US Biotest
- LiPac Oncology LLC
- University of Texas at Houston
- BCG Oncology, PC
- Johnson and Johnson
- Jiangsu Cancer Institute & Hospital
Organization Involved with Phase 1 Indications (11)
- Millennium Pharmaceuticals
- IGF Oncology, LLC
- Leadiant Biosciences, Inc.
- Fondazione Giovanni Pascale
- Virginia Commonwealth University
- Medpace, Inc.
- University of Illinois at Chicago
- GCP-Service International Ltd. & Co. KG
- Poseida Therapeutics, Inc.
- GEMoaB Monoclonals GmbH
- University of Applied Sciences Würzburg-Schweinfurt
Organization Involved with Other Experimental Indications (1)